GT Biopharma to Participate in the H.C. Wainwright Immune Cell Engager Conference on August 17, 2023 August 3, 2023
GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update March 30, 2023
GT Biopharma, Inc. Announces $6.5 Million Registered Direct Offering Priced At Premium To Market December 30, 2022